MelTec Founder, Walter Schubert of Otto von Guericke University Suspends Licensing of All His Patents to MelTec GmbH Until Completion of Structural Reorganization.Business Editors/Health/Medical Writers MAGDEBURG, Germany--(BUSINESS WIRE)--July 16, 2003 New Challenges in ALS Als (äls), Ger. Alsen, island, 121 sq mi (313 sq km), Sønderjylland co., S Denmark, in the Lille Bælt, separated from the mainland by the narrow Alensund. , in Cancer and for MELK Platform Technology Walter Schubert, founder and partner of MelTec GmbH today announced that he has suspended all his patents to MelTec GmbH until MelTec's business structure has been reorganized re·or·gan·ize v. re·or·gan·ized, re·or·gan·iz·ing, re·or·gan·iz·es v.tr. To organize again or anew. v.intr. To undergo or effect changes in organization. . Schubert is the inventor INVENTOR. One who invents or finds out something. 2. The patent laws of the United States authorize a patent to be issued to the original inventor; if the invention is suggested by another, he is not the inventor within the meaning of those laws; but in that of the patented MELK Robotic Technology, which enables protein networks to be mapped directly in morphologically mor·phol·o·gy n. pl. mor·phol·o·gies 1. a. The branch of biology that deals with the form and structure of organisms without consideration of function. b. intact cells and tissues for the first time. Schubert says that scientific work over the last few years has provided important new insights into cell function and has generated significant technological progress in MELK technology and its applications in discovering targets and drugs. Projects such as "Biochance" and "CELLECT" in particular, which the German BMBF BMBF Bundesministerium für Bildung und Forschung (German: Federal Ministry of Education and Research; Bonn, Germany) BMBF Barclays Mercantile Business Finance Limited has awarded to MelTec, the Otto-von-Guericke University of Magdeburg and other universities in Germany There are 331 universities and colleges in Germany, 159 Fachhochschulen (Universities of Applied Science), 95 non-state institutions (of these 51 privately-, 44 church-operated), and 56 which teach arts or music only. , have strongly contributed to this progress. As far as methodical me·thod·i·cal also me·thod·ic adj. 1. Arranged or proceeding in regular, systematic order. 2. Characterized by ordered and systematic habits or behavior. See Synonyms at orderly. and conceptual approaches are concerned, progress has been made in deciphering protein networks in human cells and tissues. "All protein networks together constitute the entire functional plan of a cell," said Schubert. "Given that MELK Robotic technology has been fully developed to a mature stage, it is now time to approach the systematic deciphering of the cellular protein networks in health and disease in humans." In terms of the application of MELK technology, interesting new products have been found. Indeed, a new therapeutic approach and compounds for Amyotrophic Lateral Sclerosis amyotrophic lateral sclerosis (ALS) (ā'mīətrōf`ik, sklĭrō`sĭs) or motor neuron disease, (ALS) and cancer, derived from protein network analyzes, are already in the pipeline. "Translating this new knowledge into fundamental scientific 'deciphering' projects and new developments in the marketplace poses a great challenge," said Schubert. Schubert was recently awarded three new U.S. patents related to ALS. The European Patent Office has announced that these patents will also be issued in Europe. "This paves the way for a new kind of therapy for ALS," remarked Schubert. Several further patents related to cancer are also due to be issued soon. "In terms of ALS, it is essential that every effort is made to explore the targets and disease mechanisms found and to develop a therapy," said Schubert. "For ethical reasons the development of ALS therapy has to be given absolute priority." He also intends to promote basic science for MELK technology more aggressively than before and to speed up the development of products in particular. Together, these two tasks have made necessary the reorganization of MelTec GmbH, a company founded by Schubert to develop his patents further. As a result, the existing licence contract between Schubert and MelTec GmbH has been suspended for now. As soon as reorganization of the company has been successfully completed, the licence contract will be re-established. Walter Schubert, MD Molecular Pattern Recognition Research Group Institute of Medical Neurobiology Neurobiology Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their ZENIT Building University of Magdeburg, Germany Leipziger Strasse 44 39120 Magdeburg Tel ++49-171-3217053 Fax: ++49-391-6117176 Email: Schubert@pc.mdlink.de |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion